Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.70 |
| ▸ | ALPI | P09923 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | XIAP | P98170 | 1/20 | 0.70 |
| ▸ | TPH1 | P17752 | 9/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.55 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.53 |
| ▸ | PSAT1 | Q9Y617 | 1/20 | 0.53 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7569042 | 0.98 | SLC7A5 (0.68) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL414363 | 0.91 | SLC7A5 (0.78) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL93494 | 0.91 | SLC7A5 (0.78) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL93495 | 0.91 | SLC7A5 (0.78) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL180272 | 0.91 | SLC7A5 (0.78) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL1796036 | 0.91 | SLC7A5 (0.78) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL3695982 | 0.89 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL6888643 | 0.89 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL7567510 | 0.89 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL3998569 | 0.89 | SLC7A5 (0.64) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332217-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2025-10-30 | — | — | US | claimed |
| US-12239686-B2 | Immune checkpoint inhibitor combinations | LYTIX BIOPHARMA AS (NO) | 2025-03-04 | — | — | US | claimed |
| US-20240293506-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2024-09-05 | — | — | US | claimed |
| US-20230201305-A9 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2023-06-29 | — | — | US | claimed |
| EP-3229823-B1 | CHEMOTHERAPEUTIC COMBINATIONS OF CATIONIC ANTIMICROBIAL PEPTIDES AND CHEMOTHERAPEUTICS | LYTIX BIOPHARMA AS (NO) | 2021-10-20 | — | — | EP | claimed |
| US-11123398-B2 | Chemotherapeutic combinations of cationic antimicrobial peptides and chemotherapeutics | LYTIX BIOPHARMA AS (NO) | 2021-09-21 | — | — | US | claimed |
| US-11083774-B2 | Immune checkpoint inhibitor combinations | LYTIX BIOPHARMA AS (NO) | 2021-08-10 | — | — | US | claimed |
| EP-2402364-B1 | A nonapeptide with anti-tumour activity | LYTIX BIOPHARMA AS (NO) | 2019-04-03 | — | — | EP | claimed |
| US-20180264079-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2018-09-20 | — | — | US | claimed |
| US-20170340696-A1 | CHEMOTHERAPEUTIC COMBINATIONS OF CATIONIC ANTIMICROBIAL PEPTIDES AND CHEMOTHERAPEUTICS | LYTIX BIOPHARMA AS (NO) | 2017-11-30 | — | — | US | claimed |
| EP-3230318-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | Lytix Biopharma AS (NO) | 2017-10-18 | — | — | EP | claimed |
| EP-3229823-A1 | CHEMOTHERAPEUTIC COMBINATIONS OF CATIONIC ANTIMICROBIAL PEPTIDES AND CHEMOTHERAPEUTICS | Lytix Biopharma AS (NO) | 2017-10-18 | — | — | EP | claimed |
| US-20160176923-A1 | NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY | VERRICA PHARMACEUTICALS INC. | 2016-06-23 | — | — | US | claimed |
| WO-2016091487-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2016-06-16 | — | — | WO | claimed |
| WO-2016091490-A1 | CHEMOTHERAPEUTIC COMBINATIONS OF CATIONIC ANTIMICROBIAL PEPTIDES AND CHEMOTHERAPEUTICS | LYTIX BIOPHARMA AS (NO) | 2016-06-16 | — | — | WO | claimed |
| EP-2402364-A2 | A nonapeptide with anti-tumour activity | Lytix Biopharma AS (NO) | 2012-01-04 | — | — | EP | claimed |
| US-20110318364-A1 | NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY | LYTIX BIOPHARMA AS (NO) | 2011-12-29 | — | — | US | claimed |
| US-20250332217-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2025-10-30 | — | — | US | disclosed |
| EP-2361258-A1 | A NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY | Lytix Biopharma AS (NO) | 2011-08-31 | — | — | EP | disclosed |
| WO-2010060497-A1 | A NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY | LYTIX BIOPHARMA AS (NO) | 2010-06-03 | — | — | WO | disclosed |